← Open Payments lookup

APRIL REED: Open Payments

NPI 1902490444 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,588 in 200 payments from 28 companies in 2025. Trend: 2023 $2,429 · 2024 $2,710 · 2025 $3,588

Food & beverage: $3,588
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP25$508
ABBVIE INC.23$294
Novo Nordisk Inc18$281
Boehringer Ingelheim Pharmaceuticals, Inc.13$253
Actelion Pharmaceuticals US, Inc.10$249
Merck Sharp & Dohme LLC9$201
GlaxoSmithKline, LLC.14$163
Lilly USA, LLC12$159
GENZYME CORPORATION6$120
Axsome Therapeutics, Inc.6$118

Products named: TEZSPIRE, DUPIXENT, ZERBAXA, Wegovy, OFEV, OPSUMIT, Sunosi, GEMTESA.

Industry payments across AL — which companies pay providers there.